Traduction de «restraints in long-term » (Néerlandais → Français) :

156. Mohler R, Richter T, Kopke S, Meyer G. Interventions for preventing and reducing the use of physical restraints in long-term geriatric care.
156. Mohler R, Richter T, Kopke S, Meyer G. Interventions for preventing and reducing the use of physical restraints in long-term Reviews. geriatric care.

Moody’s rated the Group as Aa2 for long-term maturities and P-1 for short-term maturities and Standard & Poor’s had a rating of AA- and A-1+, for long-term and short-term maturities, respectively. Fitch had a long-term rating of AA and a short-term rating of F1+.
Moody’s a noté le Groupe Aa2 pour les maturités longues et P-1 pour les maturités courtes, Standard & Poor’s respectivement AA- et A-1+ et Fitch respectivement AA et F1+.

Moody’s rated the Group as Aa2 for long-term maturities and P-1 for short-term maturities, and Standard & Poor’s had ratings of AA- for long-term and A-1+ for short-term maturities. Fitch had a long-term rating of AA and a short-term rating of F1+.
Moody’s a noté le Groupe Aa2 pour les maturités longues et P-1 pour les maturités courtes, Standard & Poor’s respectivement AA- et A-1+ et Fitch respectivement AA et F1+.

Moody’s rated the Group as Aa2 for long-term maturities and P-1 for short-term maturities and Standard & Poor’s had a rating of AA- and A-1+, for long-term and shortterm maturities, respectively.
Moody’s a noté le Groupe Aa2 pour les maturités longues et P-1 pour les maturités courtes, Standard & Poor’s respectivement AA- et A-1+ et Fitch respectivement AA et F1+.

Achieving success with long-term R&D investments Novartis has been reaping the benefits of long-term, disciplined investments in innovation, achieving more than 30 major regulatory approvals and significant progress in the Group’s R&D pipeline so far in 2009.
Succès des investissements à long terme dans la R&D Novartis a récolté les fruits d'investissements judicieux à long terme dans l'innovation. Il a en effet obtenu plus de 30 autorisations majeures de mise sur le marché et réalisé à ce jour en 2009 d’importants progrès dans le pipeline de R&D du Groupe.

L’échantillon est cependant petit et l’évaluation ne porte pas sur le long terme En cherchant Mackenzie, j’ai trouvé 2 articles (Praissman 2008 et
L’échantillon est cependant petit et l’évaluation ne porte pas sur le long terme En cherchant Mackenzie, j’ai trouvé 2 articles (Praissman 2008 et Cohen-Katz 2004) qui survole la littérature consacrée au MBSR notamment parmi les healthcare professionals et

Externe experten: Health Promotion Group : Luc Berghmans (Observatoire de la santé du Hainaut), Lien Braeckevelt (WVG Vlaanderen), Christian De Bock (CM), Léa Maes (UGent), Myriam De Spiegelaere (ULB – Observatoire de la santé Bruxelles), Stephan Van Den Broucke (UCL), Chantal Vandoorne (ULg), Alexander Witpas (WVG Vlaanderen) Mental Healthcare Group: Joël Boydens (CM), Robert Cools (CGG - De Pont), Raf De Rycke (Broeders van Liefde), Pol Gerits (FOD Volksgezondheid – SPF Santé Publique), Jean-Pierre Gorissen (FOD Volksgezondheid – SPF Santé Publique), Bernard Jacob (SPF Santé publique – FOD Volksgezondheid), Gert Peeters (UZ Leuven), Jean-Paul Roussaux (Cliniques Universitaires St-Luc) Continuity of Care and Patient Centeredness Group: Corinne Boüüaert (Maison Médicale Bautista Van Schowen), Xavier de Béthune (CM), Veerle Foulon (KU Leuven), Mirco Petrovic (UZ Gent), Luc Seuntjens (het Artsenhuis), Anne Spinewine (UCL de Mont-Godinne), Johan Van der Heyden (WIV - ISP), Annelies Van Linden (Domus Medica), Johan Wens (UA) Long term care Group: Daniel Crabbe (RIZIV – INAMI), Jan Delepeleire (KU Leuven), Johan Flaming (UZ Leuven), Margareta Lambert (UZ Brussel), Jean Macq (UCL), Alex Peltier (MC), Luc Van Gorp (Katholieke Hogeschool Limburg), Isabelle Vanderbrempt (SPF Santé publique – FOD Volksgezondheid ) End of Life Group: Joachim Cohen (VUB), Marianne Desmedt (UCL), Rita Goetschalckx (RIZIV – INAMI), Johan Menten (UZ Leuven), Kathleen Kleemans (VUB), Birgit Gielen (CM)
Experts externes : Health Promotion Group : Luc Berghmans (Observatoire de la santé du Hainaut), Lien Braeckevelt (WVG Vlaanderen), Christian De Bock (CM), Léa Maes (UGent), Myriam De Spiegelaere (ULB – Observatoire de la santé Bruxelles), Stephan Van Den Broucke (UCL), Chantal Vandoorne (ULg), Alexander Witpas (WVG Vlaanderen) Mental Healthcare Group: Joël Boydens (CM), Robert Cools (CGG - De Pont), Raf De Rycke (Broeders van Liefde), Pol Gerits (FOD Volksgezondheid – SPF Santé Publique), Jean-Pierre Gorissen (FOD Volksgezondheid – SPF Santé Publique), Bernard Jacob (SPF Santé publique – FOD Volksgezondheid), Gert Peeters (UZ Leuven), Jean-Paul Roussaux (Cliniques Universitaires St-Luc) Continuity of Care and Patient Centeredness Group: Corinne Boüüaert (Maison Médicale Bautista Van Schowen), Xavier de Béthune (CM), Veerle Foulon (KU Leuven), Mirco Petrovic (UZ Gent), Luc Seuntjens (het Artsenhuis), Anne Spinewine (UCL de Mont-Godinne), Johan Van der Heyden (WIV - ISP), Annelies Van Linden (Domus Medica), Johan Wens (UA) Long term care Group: Daniel Crabbe (RIZIV – INAMI), Jan Delepeleire (KU Leuven), Johan Flaming (UZ Leuven), Margareta Lambert (UZ Brussel), Jean Macq (UCL), Alex Peltier (MC), Luc Van Gorp (Katholieke Hogeschool Limburg), Isabelle Vanderbrempt (SPF Santé publique – FOD Volksgezondheid ) End of Life Group: Joachim Cohen (VUB), Marianne Desmedt (UCL), Rita Goetschalckx (RIZIV – INAMI), Johan Menten (UZ Leuven), Kathleen Kleemans (VUB), Birgit Gielen (CM)

Comité Sociale bescherming, Preliminary National Report on Health Care & long-term Care, België, april 2005, bijlage.
Comité de la protection sociale, Preliminary national report on health care & long-term care, Belgique, avril 2005, annexe.

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).

‘We do everything we can to operate in a manner that is sustainable: economically, socially, and environmentally – in the best interest of long-term success for our enterprise’.
« Nous entreprenons tous les efforts nécessaires pour opérer dans une optique de développement durable, tant sur le plan économique et social que de l’environnement, afin d’assurer la réussite à long terme de notre entreprise».